Latest Press Releases

Loading…
See all Press Releases

Financial Calendar

Annual Report 2018
Interim report Q1, 2019
Annual General Meeting 2019
Interim report Q2, 2019
Interim report Q3, 2019

Contact Investor Relations
Martin Åmark, CEO/IR
+46 (0) 763 09 37 77
martin.amark@xbrane.com

Company
Presentation

Financial Hearings
Börsveckan
Stockholm, Sweden
February 19, 2019

Presenter:

Martin Åmark, CEO Xbrane Biopharma